Training Director, General Psychiatry Program
|B.S.||Biomedical Engineering, University of Southern California|
|M.D.||University of Southern California School of Medicine|
|Internship/Residency||University of Southern California/Los Angeles County General Hospital|
Dr. Burgoyne has been the training director for Harbor-UCLA’s Department of Psychiatry for the last five years. He also serves on the Los Angeles County Department of Mental Health’s Executive Management Team. His primary clinical research areas in psychopharmacology involve most second generation antipsychotics, many novel antidepressants, and some anxiolytics. Multicentered projects include CATIE and STAR-D. His more recent research efforts have focused on the prediction of antidepressant responses using quantitative EEG measurements.
Burgoyne, K., Swartz, R., Ananth, J., “Porphyria: Reexamination of Psychiatric Implications”. Psychotherapy and Psychosomatics, 1995;64:121-130. (review article)
Burgoyne, K., Ananth, J., “Hypnotics”. Text-Book of Psychopharmacology, Jambur Ananth (ed). Jaypee Brothers publishing.New Delhi, (book chapter) 1999
Swartz R., Burgoyne K., Smith M., Ananth J. “Tardive Dyskinesia and Ethnicity: A Review of the literature”. Annals of Clinical Psychiatry 9:53-59, 1997
Ananth J, Burgoyne K, Aquino S: “Meige’s Syndrome Associated with Risperidone Therapy.” American J Psychiatry 157:149, 2000
Ananth J, Burgoyne K, Gadasalli R, Aquino S: “How do the Atypical Antipsychotics Work?” Journal of Psychiatry & Neuroscience 26(5):385-394, 2001
Ananth J., Venkatesh R, Burgoyne K, Gunatilake S: “Atypical antipsychotic drug use and diabetes”. Psychotherapy and Psychosomatics 71:244-254, 2002
Ananth J, Burgoyne K, Niz D, Smith M: Tardive dyskinesia in two patients who were treated only with ziprasidone. Journal of Psychiatry & Neuroscience 29(2), March 2004
Ananth J, Venkatesh R, Burgoyne K, Gadasalli R, Binford R, Gunatilake S: Atypical antipsychotics induced weight gain: Pathophysiology and Management. Annals of Clinical Psychiatry, February 2004.
Leuchter AF, et al: “Predictors of Clinical Response and Remission to Escitalopram Treatment”. The American College of Neuro-psychopharmacology 2007